key information
- Location: Hilton London Kensington, 179-199 Holland Park Avenue, London W11 4UL, United Kingdom
- March 7-8, 2024
- 8:30 - 17:30 Local Time
OUR CONFERENCE PROGRAM
This is not just another PPM conference. This is a conference which tells you a STORY. One story, followed by another, stories of exceptional people who happen to choose Project and Portfolio Management as their way to bring needed medicines to improve the health of millions of people on our planet. Our conference will feature numerous assisted networking sessions which will help you create those critical business friendships needed for fruitful cooperation with professionals from the industry for many years to come. We believe, that our thoughtfully planned conference will fill in any missing pieces in your
plans on the mission to deliver your projects faster, more efficiently and with ease and satisfaction.
Main Takeaways
- Leveraging technologies for improved decision making
- Deciding on the right mix of therapeutic areas
- Decision analysis and structured decision making
- Assesing portfolio risk and return under multiple future scenario predictions
- Governance and risk management
- Deep dive into artificial intelligence (AI), machine learning, and predictive analytics to improve decision-making
- Alligining project and program execution to corporate strategy
- Capacity planning in a resource-constrained environment
Testimonials
- 38% CXO, MD, Chairman, President, VP, Executive Director & General Manager
- 27% Senior Patient Experience/Relations Management & Service Excellence Executives
- 20% Administration & Quality assurance management
- 15% Others: Nursing management, Clinicians, data management, pharmacy directors
Past Event Speakers
Irena Prasilova
MSD
Marianna Esposito
Intelligencia AI
Phil Mallinder
AstraZeneca
Maya Zergui-Donain
Sanofi
Bahadir Cakmak
Sandoz
Anna Cyranka
Alvotech
Lukasz Krawczyk
Polpharma Biologics Gdansk
Mirjam Foti
Pharming Group
Jörn Lenz
medac
Karen Skinner
LifeArc
Ruppen Nalbandian
AstraZeneca
Silke Rodrigues
medac
Tracy Mak
Evariste
Tom Halliwell
Gurpreet Singh
Integrated Safety IQVIA
Michael Has
MSD
Estelle Bernard-Fichet
BitBio
Sandra Hirschberg
Bicycle Therapeutics
Vincenzo Garzya
AstraZeneca
Richard Bayney
PPVC
Stefanie Abt
AET - Alfred E. Tiefenbacher
Keith Rodgers
Strategic Adviser, Inngenii Ltd
Projects Director, Novitious LLC
PIPMG Exec Team Member
HELD AT THE SAME VENUE
PROJECT, PROGRAM, AND PORTFOLIO RISK ANALYSIS MASTERCLASS
Learn how to quantify and manage risk at project, program, and portfolio levels. Assess the extent to which multiple indications and/or lines of therapy affect program risk and valuation.
- London, United Kingdom
- March 5-6, 2024
- 8:00 - 17:00 Local Time
-
Course Leader: Dr. Richard Bayney,
President & Founder of Project & Portfolio Value Creation.
REGISTRATION
Conference
ticket | March 7-8, 2024-
Access to All Conference Sessions of 26th European Pharma and Biotech Project, Program and Portfolio Management Conference London
-
Access to Post Conferences Networking
-
Conference Materials
-
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch
Masterclass
ticket | March 5-6, 2024-
Project, program, and portfolio risk analysis Masterclass with Industry Veteran Richard Bayney
-
One-on-one coaching
-
Copy of 2022's “The State of Portfolio Management” Benchmark Report
-
Design sessions for direct application
-
Benchmarks to identify your organization's performance gaps
Masterclass + Conference
ticket | March 5-8, 2024-
Grants all Masterclass and Conference Ticket Benefits including access to the Project, program, and portfolio risk analysis Masterclass + 26th European Pharma And Biotech Project, Program And Portfolio Management Conference at a special rate.
event partners
GOLD SPONSOR
Planisware is a global provider of software solutions for project portfolio management. Planisware solutions are specifically designed to support product development, engineering and IT business processes. For more than 20 years, Planisware has been helping its customers to achieve strategic and innovative excellence, make valid business decisions and increase portfolio value. Today, over 500 companies worldwide rely on Planisware products to manage their projects, resources and portfolios.
GOLD SPONSOR
Founded in 2017, Intelligencia AI™ is at the forefront of using data science and artificial intelligence (AI) to address significant challenges in the pharmaceutical industry: extremely long drug development timelines, sky-high costs, and unsustainable ROI. Its suite of AI-powered solutions is built on expertly curated scientific and clinical data. The solutions provide actionable insights that help de-risk drug development by providing an accurate, unbiased assessment of a drug’s probability of success at critical points in the drug development process.
Intelligencia AI is headquartered in New York, NY, with offices in San Francisco, CA, and Athens, Greece, and employs 110 individuals globally. Visit intelligencia.ai to discover more.
